ConductScience.org, home

Paper786295

Significance of persisting serologic abnormalities in SLE.

Lightfoot RW and 1 other. Arthritis Rheum, 1976. Cited by 99 papers, by iCite.

Cite this record

ConductScience Library. Significance of persisting serologic abnormalities in SLE. Papers, record 786295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/786295

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significance of persisting serologic abnormalities in SLE.
PubMed
Journal
Arthritis Rheum
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
99
iCite
Relative citation ratio, by iCite
3.88
iCite
Revised in PubMed
2019-07-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lightfoot RW JrR W
2Hughes GRG R

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, AntinuclearMajor topic
Complement System ProteinsMajor topic
DNAMajor topic
Lupus Erythematosus, SystemicMajor topic
Adult
Female
Humans
Immunologic Techniques
Male
Recurrence
Remission, Spontaneous

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.

PMIDTitleJournalYearIn PapersSource
7979578Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.Ann Rheum Dis1994https://conductscience.org/library/papers/7979578PubMed
7006525Seronegative chronic polyarthritis: clinical and serological correlates.Ann Rheum Dis1980https://conductscience.org/library/papers/7006525PubMed
6981385Prognostic value of anti-dsDNA in SLE.Ann Rheum Dis1982https://conductscience.org/library/papers/6981385PubMed
6968757Antibody to synthetic poly dAT: correlation with antibody to native DNA and specificity for SLE.J Clin Pathol1980https://conductscience.org/library/papers/6968757PubMed
6859963A new specific assay for the detection of DNA immune complexes: its relevance in SLE.Ann Rheum Dis1983https://conductscience.org/library/papers/6859963PubMed
6761831Circulating DNA-antibodies in systemic lupus erythematosus.Rheumatol Int1982https://conductscience.org/library/papers/6761831PubMed
6608131DNA antibodies and complement in SLE patients. A follow-up study.Rheumatol Int1983https://conductscience.org/library/papers/6608131PubMed
6333314Azathioprine in the treatment of systemic lupus erythematosus. A three-year prospective study.Clin Rheumatol1984https://conductscience.org/library/papers/6333314PubMed
6156950Secondary structure in denatured DNA is responsible for its reaction with antinative DNA antibodies of systemic lupus erythematosus sera.J Clin Invest1980https://conductscience.org/library/papers/6156950PubMed
6153184Reaction of systemic lupus erythematosus antinative DNA antibodies with native DNA fragments from 20 to 1,200 base pairs.J Clin Invest1980https://conductscience.org/library/papers/6153184PubMed
3877968Correlation of disease activity with circulating immune complexes (C1qbA) and complement breakdown products (C3D) in patients with systemic lupus erythematosus. A prospective study.Rheumatol Int1985https://conductscience.org/library/papers/3877968PubMed
3872638Reduced opsonisation of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus.Ann Rheum Dis1985https://conductscience.org/library/papers/3872638PubMed
3872637Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA).Ann Rheum Dis1985https://conductscience.org/library/papers/3872637PubMed
3792382Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis.Eur J Pediatr1986https://conductscience.org/library/papers/3792382PubMed
3753037Antibodies to histones and disease activity in systemic lupus erythematosus: a comparative study with an enzyme-linked immunosorbent assay and immunoblotting.Arch Dermatol Res1986https://conductscience.org/library/papers/3753037PubMed
3581695Systemic lupus erythematosus. Follow-up study of 148 patients. II: Predictive factors of importance for course and outcome.Clin Rheumatol1987https://conductscience.org/library/papers/3581695PubMed
3492026Complement (C3) metabolism in systemic lupus erythematosus in relation to the disease course.Rheumatol Int1986https://conductscience.org/library/papers/3492026PubMed
3488149T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2.Clin Exp Immunol1986https://conductscience.org/library/papers/3488149PubMed
3487292Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.Ann Rheum Dis1986https://conductscience.org/library/papers/3487292PubMed
3319358Attempts towards a serological diagnosis of ankylosing spondylitis.Clin Rheumatol1987https://conductscience.org/library/papers/3319358PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/786295

GET https://conductscience.org/api/papers/v1/786295/cited_by?page=2